Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Change in Receivables (2021 - 2024)

Cingulate's (CING) quarterly Change in Receivables came in at -$12375.0 in Q1 2024, up 93.89% on a YoY basis from -$6382.5 in Q2 2023, and down 240.85% quarter-over-quarter from $8786.0 in Q4 2023.

Analysis

Cingulate (CING) Change in Receivables (2021 - 2024) Analysis & Trends

Cingulate (CING) has reported Change in Receivables for 4 consecutive years, with -$12375.0 the latest figure, recorded in Q1 2024.

  • For the quarter ending Q1 2024, Change in Receivables rose 93.89% year-over-year to -$12375.0; the trailing twelve-month figure through Mar 2024 stood at -$29706.0 (up 95.2% YoY), and the FY2025 full-year result was -$18312.0, down 256.47% from the prior year.
  • Change in Receivables fell to -$12375.0 in Q1 2024 per CING's latest filing, from $8786.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $333186.0 in Q4 2021 and bottomed at -$511258.0 in Q2 2022.
  • Historically, Change in Receivables has averaged -$11501.9 across 4 years, with a median of $3517.0 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Change in Receivables plunged 787.17% in 2022, then surged 100.69% in 2023.
  • Over 4 years, Change in Receivables stood at $333186.0 in 2021, then tumbled by 43.85% to $187083.0 in 2022, then slumped by 95.3% to $8786.0 in 2023, then tumbled by 240.85% to -$12375.0 in 2024.
  • According to Business Quant data, Change in Receivables over the past three periods registered -$12375.0, $8786.0, and -$29634.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 1.35 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 1.37 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 1.18 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 117.58 Mn
10 Cingulate 72.81 Mn 72.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -12,375.00
Dec 31, 2023 8,786.00
Sep 30, 2023 -29,634.00
Jun 30, 2023 3,517.00
Mar 31, 2023 -202,479.00
Dec 31, 2022 187,083.00
Sep 30, 2022 -92,764.00
Jun 30, 2022 -511,258.00
Mar 31, 2022 -38,877.00
Dec 31, 2021 333,186.00
Sep 30, 2021 76,762.00
Jun 30, 2021 74,400.00
Mar 31, 2021 54,128.00
API Access

Cingulate Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=CING&period=max&api_key=YOUR_API_KEY